Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Embryo Ventures is a London-based venture capital firm that partners with exceptional founders globally. The organization focuses on early-stage investments, managing a portfolio of 12 companies. Their investment strategy emphasizes sectors related to Human Health and Human Experience.
Embryo Ventures invests in pre-seed to Series A stages, targeting innovative technologies in healthcare and consumer sectors. They back ventures that aim to restore, sustain, and expand human health, as well as those that redefine essential daily life systems.
Notable portfolio companies include PLUVO, Thermulon, Cheeky Panda, LAKA, BioLumen, and TasteIndex. Other companies in their portfolio are Calla Lily Clinical Care, STAXY, GLADYS, Bridgefy, Stealth, OSSTEC, and IMPLI.
Email hello@embryoventures.com with your deck to pitch them.
Embryo Ventures often leads investment rounds, particularly in early-stage ventures that align with their focus on human health and experience.
The firm is open to follow-on investments, especially for portfolio companies that demonstrate significant growth potential and alignment with their investment thesis.
Specific details about the size of Embryo Ventures' current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.